Prolacta Bioscience

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Prolacta Bioscience sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 5 completed early-phase tilt upper quartile by trial count

Prolacta Bioscience: 7 sponsored US clinical trials, none currently recruiting.

Prolacta Bioscience sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Infant, Very Low Birth Weight, with 1 trials.

Upper-quartile sponsor footprint

Prolacta Bioscience sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

TERMINATED Phase 2

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

NCT06102213
COMPLETED

Dietary Supplement With and Without a Probiotic and/or Antibiotic

NCT05141903
COMPLETED NA

Dietary Supplement With and Without a Probiotic

NCT04433208
TERMINATED Phase 1

A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

NCT03793686
COMPLETED Phase 1

Safety Study of Human Milk Oligosaccharides in Healthy Adults

NCT05516225
COMPLETED NA

Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants

NCT00506584
COMPLETED NA

Evaluation of Prolact-Plus Human Milk Fortifier

NCT00486590

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Therapeutic Areas

Infant, Very Low Birth Weight 1
Healthy Adults 1

How the Prolacta Bioscience early-phase archive is shaped

7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).

Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Infant, Very Low Birth Weight (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Prolacta Bioscience: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Prolacta Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Prolacta Bioscience3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Prolacta Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Prolacta Bioscience sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Prolacta Bioscience page

7 registered trials is a research-attention snapshot, not an endorsement of Prolacta Bioscience or any single study.

  • None of Prolacta Bioscience's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Infant, Very Low Birth Weight is the condition Prolacta Bioscience studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Infant, Very Low Birth Weight trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Prolacta Bioscience pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.